Review Article| Volume 33, ISSUE 3, P505-525, September 2013

Invasive Fungal Infections

Biomarkers and Molecular Approaches to Diagnosis


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Klutts J.S.
        • Robinson-Dunn B.
        A critical appraisal of the role of the clinical microbiology laboratory in diagnosis of invasive fungal infections.
        J Clin Microbiol. 2011; 49: S39-S42
        • Berenguer J.
        • Buck M.
        • Witebsky F.
        • et al.
        Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis.
        Diagn Microbiol Infect Dis. 1993; 17: 103-109
        • Biomarkers Definitions Working Group
        Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.
        Clin Pharmacol Ther. 2001; 69: 89-95
        • Stynen D.
        • Sarfati J.
        • Goris A.
        • et al.
        Rat monoclonal antibodies against Aspergillus galactomannan.
        Infect Immun. 1992; 60: 2237-2245
        • Petraitiene R.
        • Petraitis V.
        • Groll A.H.
        • et al.
        Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.
        Antimicrob Agents Chemother. 2001; 45: 857-869
        • Miceli M.H.
        • Grazziutti M.L.
        • Woods G.
        • et al.
        Strong correlation between serum Aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications.
        Clin Infect Dis. 2008; 46: 1412-1422
        • Anaissie E.J.
        Trial design for mold-active agents: time to break the mold—aspergillosis in neutropenic adults.
        Clin Infect Dis. 2007; 44: 1298-1306
        • Klont R.R.
        • Mennink-Kersten M.A.
        • Verweij P.E.
        Utility of Aspergillus antigen detection in specimens other than serum specimens.
        Clin Infect Dis. 2004; 39: 1467-1474
        • Lengerova M.
        • Kocmanova I.
        • Racil Z.
        • et al.
        Detection and measurement of fungal burden in a guinea pig model of invasive pulmonary aspergillosis by novel quantitative nested real-time PCR compared with galactomannan and (1,3)-β-D-glucan detection.
        J Clin Microbiol. 2012; 50: 602-608
        • Husain S.
        • Clancy C.J.
        • Nguyen M.H.
        • et al.
        Performance characteristics of the Platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid.
        Clin Vaccine Immunol. 2008; 15: 1760-1763
        • Becker M.J.
        • Lugtenburg E.J.
        • Cornelissen J.J.
        • et al.
        Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis.
        Br J Haematol. 2003; 121: 448-457
        • Meersseman W.
        • Lagrou K.
        • Maertens J.
        • et al.
        Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing pulmonary aspergillosis in intensive care unit patients.
        Am J Respir Crit Care Med. 2008; 177: 27-34
        • Oz Y.
        • Kiraz N.
        Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods.
        Expert Rev Anti Infect Ther. 2011; 9: 289-298
        • Verweij P.E.
        • Weemaes C.M.
        • Curfs J.H.
        • et al.
        Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis.
        J Clin Microbiol. 2000; 38: 3900-3901
        • Marr K.A.
        • Balajee S.A.
        • McLaughlin L.
        • et al.
        Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance.
        J Infect Dis. 2004; 190: 641-649
        • Sulahian A.
        • Touratier S.
        • Ribaud P.
        False positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam.
        N Engl J Med. 2003; 349: 2366-2367
        • Mennink-Kersten M.A.
        • Klont R.R.
        • Warris A.
        • et al.
        Bifidobacterium lipoteichoic acid and false ELISA reactivity in Aspergillus antigen detection.
        Lancet. 2004; 363: 325-327
        • Girmenia C.
        • Santilli S.
        • Ballaro D.
        • et al.
        Enteral nutrition may cause false-positive results of Aspergillus galactomannan assay in absence of gastrointestinal diseases.
        Mycoses. 2011; 54: e883-e884
        • Petraitiene R.
        • Petraitis V.
        • Witt J.R.
        • et al.
        Galactomannan antigenemia after infusion of gluconate-containing Plasma-Lyte.
        J Clin Microbiol. 2011; 49: 4330-4332
        • Mikulska M.
        • Furfaro E.
        • Del Bono V.
        • et al.
        Galactomannan testing might be useful for early diagnosis of fusariosis.
        Diagn Microbiol Infect Dis. 2012; 72: 367-369
        • Van den Bossche D.
        • De Bel A.
        • Hendrickx M.
        • et al.
        Galactomannan enzymatic immunoassay cross-reactivity caused by Prototheca species.
        J Clin Microbiol. 2012; 50: 3371-3373
        • Vergidis P.
        • Walker R.C.
        • Kaul D.R.
        • et al.
        False-positive Aspergillus galactomannan assay in solid organ transplant recipients with histoplasmosis.
        Transpl Infect Dis. 2012; 4: 213-217
        • Van der Veer J.
        • Lewis R.J.
        • Emtiazjoo A.M.
        • et al.
        Cross-reactivity in the Platelia Aspergillus enzyme immunoassay caused by blastomycosis.
        Med Mycol. 2012; 50: 396-398
        • Mikulska M.
        • Furfaro E.
        • Del Bono V.
        • et al.
        Piperacillin/tazobactam (Tazocin) seems to be no longer responsible for false-positive results of the galactomannan assay.
        J Antimicrob Chemother. 2012; 67: 1746-1748
        • D’Haese J.
        • Theunissen K.
        • Vermeulen E.
        • et al.
        Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity.
        J Clin Microbiol. 2012; 50: 1258-1263
        • Maertens J.
        • Maertens V.
        • Theunissen K.
        • et al.
        Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases.
        Clin Infect Dis. 2009; 49: 1688-1693
        • De Pauw B.
        • Walsh T.J.
        • Donnelly J.P.
        • et al.
        Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.
        Clin Infect Dis. 2008; 46: 1813-1821
        • Ruhnke M.
        • Bohme A.
        • Buchheidt D.
        • et al.
        Diagnosis of invasive fungal infections in hematology and oncology- guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO).
        Ann Oncol. 2012; 23: 823-833
        • Walsh T.J.
        • Anaissie E.J.
        • Denning D.W.
        • et al.
        Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.
        Clin Infect Dis. 2008; 46: 327-360
        • Chen S.C.
        • Kontoyiannis D.P.
        New molecular and surrogate biomarker-based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic patients.
        Curr Opin Infect Dis. 2010; 23: 567-577
        • Lengerova M.
        • Kocmanova I.
        • Hrncirova K.
        • et al.
        Comparison of quantitative real-time PCR (Q-RT-PCR), galactomannan enzyme immunoassay (GM) and 1,3-beta-D-glucan detection (BG) in a guinea pig model of invasive aspergillosis. Abstract M-1696a. Abstracts of the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September, 2009. In: Patterson TF. Clinical utility and development of biomarkers in invasive aspergillosis.
        Trans Am Clin Climatol Assoc. 2011; 122: 174-183
        • Nouer S.A.
        • Nucci M.
        • Kumar N.S.
        • et al.
        Earlier response assessment in invasive aspergillosis based on the kinetics of serum Aspergillus galactomannan: proposal for a new definition.
        Clin Infect Dis. 2011; 53: 671-676
        • Segal B.H.
        • Herbrecht R.
        • Stevens D.A.
        • et al.
        Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.
        Clin Infect Dis. 2008; 47: 674-683
        • Girouard G.
        • Lachance C.
        • Pelletier R.
        Observations on (1-3)-β-D-glucan detection as a diagnostic tool in endemic mycosis caused by Histoplasma or Blastomyces.
        J Med Microbiol. 2007; 56: 1001-1002
        • Obayashi T.
        • Yoshida M.
        • Tamura H.
        • et al.
        Determination of plasma (1→3) β-D-glucan: a new diagnostic aid to deep mycosis.
        J Med Vet Mycol. 1992; 30: 275-280
        • Lu Y.
        • Chen Y.
        • Guo Y.
        • et al.
        Diagnosis of invasive fungal disease using serum (1→3)-β-D-glucan: a bivariate meta-analysis.
        Intern Med. 2011; 50: 2783-2791
        • Lamoth F.
        • Cruciani M.
        • Mengoli C.
        • et al.
        β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3).
        Clin Infect Dis. 2012; 54: 633-643
        • Fontana C.
        • Gaziano R.
        • Favaro M.
        • et al.
        (1-3)-β-D-Glucan vs galactomannan antigen in diagnosing invasive fungal infections (IFIs).
        Open Microbiol J. 2012; 6: 70-73
        • Pazos C.
        • Ponton J.
        • Del Palacio A.
        Contribution of (1→3)-β-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.
        J Clin Microbiol. 2005; 43: 299-305
        • Obayashi T.
        Reappraisal of the serum (1→3) β-D-glucan for the diagnosis of invasive fungal infections: a study based on autopsy cases from 6 years.
        Clin Infect Dis. 2008; 46: 1864-1870
        • Alam F.F.
        • Mustafa A.S.
        • Khan Z.U.
        Comparative evaluation of (1,3)-β-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia.
        BMC Infect Dis. 2007; 7: 103
        • Mohr J.F.
        • Sims C.
        • Paetznick V.
        • et al.
        Prospective survey of (1→3) β-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting.
        J Clin Microbiol. 2011; 49: 58-61
        • Leon C.
        • Ruiz-Santana S.
        • Saavedra P.
        • et al.
        Value of β-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions.
        Intensive Care Med. 2012; 38: 1315-1325
        • Jaijakul S.
        • Vazquez J.A.
        • Swanson R.N.
        • et al.
        (1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis.
        Clin Infect Dis. 2012; 55: 521-526
        • Eggimann P.
        • Marchetti O.
        Is (1→3)-β-D-glucan the missing link from bedside assessment to pre-emptive therapy of invasive candidiasis?.
        Crit Care. 2011; 15: 1017
        • Karageorgopoulos D.E.
        • Qu J.M.
        • Korbila I.P.
        • et al.
        Accuracy of β-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis.
        Clin Microbiol Infect. 2013; 19: 39-49
        • Egan L.
        • Connolly P.
        • Wheat L.J.
        • et al.
        Histoplasmosis as a cause for a positive Fungitell (1→3)-β-D-glucan test.
        Med Mycol. 2008; 46: 93-95
        • Wingard J.R.
        Have novel serum markers supplanted tissue diagnosis for invasive fungal infections in acute leukemia and transplantation?.
        Best Pract Res Clin Haematol. 2012; 25: 487-491
        • Ostrosky-Zeichner L.
        Invasive mycoses: diagnostic challenges.
        Am J Med. 2012; 125: S14-S24
        • Mikulska M.
        • Calandra T.
        • Sanguinetti M.
        • et al.
        The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia.
        Crit Care. 2010; 14: R222
        • Pappas P.G.
        • Kauffman C.A.
        • Andes D.
        • et al.
        Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.
        Clin Infect Dis. 2009; 48: 503-535
        • Lain A.
        • Elguezabal N.
        • Moragues M.D.
        • et al.
        Contribution of serum biomarkers to the diagnosis of invasive candidiasis.
        Expert Rev Mol Diagn. 2008; 8: 315-325
        • Lehtonen L.
        • Anttila V.J.
        • Ruutu T.
        • et al.
        Diagnosis of disseminated candidiasis by measurement of urine D-arabinitol/L-arabinitol ratio.
        J Clin Microbiol. 1996; 34: 2175-2179
        • Khot P.D.
        • Fredricks D.N.
        PCR-based diagnosis of human fungal infections.
        Expert Rev Anti Infect Ther. 2009; 7: 1201-1221
        • Hall L.
        • Le Febre K.M.
        • Deml S.M.
        • et al.
        Evaluation of the Yeast Traffic Light PNA FISH probes for identification of Candida species from positive blood cultures.
        J Clin Microbiol. 2012; 50: 1446-1448
        • Farina C.
        • Perin S.
        • Andreoni S.
        • et al.
        Evaluation of the peptide nucleic acid fluorescence in situ hybridization technology for yeast identification directly from positive blood cultures: an Italian experience.
        Mycoses. 2012; 55: 388-392
        • Morrell M.
        • Fraser V.J.
        • Kollef M.H.
        Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality.
        Antimicrob Agents Chemother. 2005; 49: 3640-3645
        • Balada-Llasat J.
        • LaRue H.
        • Kamboj K.
        • et al.
        Detection of yeasts in blood cultures by the Luminex xTAG fungal assay.
        J Clin Microbiol. 2012; 50: 492-494
        • Babady N.E.
        • Miranda E.
        • Gilhuley K.A.
        Evaluation of Luminex xTAG fungal analyte-specific reagents for rapid identification of clinically relevant fungi.
        J Clin Microbiol. 2011; 49: 3777-3782
        • Buelow D.R.
        • Gu Z.
        • Walsh T.J.
        • et al.
        Evaluation of multiplexed PCR and liquid-phase array for identification of respiratory fungal pathogens.
        Med Mycol. 2012; 50: 775-780
        • Luong M.L.
        • Clancy C.J.
        • Vadnerkar A.
        • et al.
        Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients.
        Clin Infect Dis. 2011; 52: 1218-1226
        • Nguyen M.H.
        • Wissel M.C.
        • Shields R.K.
        • et al.
        Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.
        Clin Infect Dis. 2012; 54: 1240-1248
        • Gu Z.
        • Hall T.A.
        • Frinder M.
        • et al.
        Evaluation of repetitive sequence PCR and PCR-mass spectrometry for the identification of clinically relevant Candida species.
        Med Mycol. 2012; 50: 259-265
        • White P.L.
        • Perry M.D.
        • Moody A.
        • et al.
        Evaluation of analytical and preliminary clinical performance of Myconostica MycAssay Aspergillus when testing serum specimens for diagnosis of invasive aspergillosis.
        J Clin Microbiol. 2011; 49: 2169-2174
        • Torelli R.
        • Sanguinetti M.
        • Moody A.
        • et al.
        Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to galactomannan enzyme immunoassay.
        J Clin Microbiol. 2011; 49: 4273-4278
        • Lucignano B.
        • Ranno S.
        • Liesenfeld O.
        • et al.
        Multiplex PCR allows rapid and accurate diagnosis of bloodstream infections in newborns and children with suspected sepsis.
        J Clin Microbiol. 2011; 49: 2252-2258
        • Lau A.
        • Halliday C.
        • Chen S.C.
        • et al.
        Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR.
        J Clin Microbiol. 2010; 48: 811-816
      1. Great Basin Corporation. Available at: Accessed January 14, 2013.

      2. RenDx Fungiplex panel. Available at:–17069. Accessed January 20, 2013.

      3. T2 Biosystems. Available at: Accessed January 20, 2013.

        • Zhao Y.
        • Park S.
        • Kreiswirth B.N.
        • et al.
        Rapid real-time nucleic acid sequence-based amplification-molecular beacon platform to detect fungal and bacterial bloodstream infections.
        J Clin Microbiol. 2009; 47: 2067-2078
        • Dhiman N.
        • Hall L.
        • Wohlfiel S.L.
        • et al.
        Performance and cost analysis of matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine identification of yeast.
        J Clin Microbiol. 2011; 49: 1614-1616
        • Yan Y.
        • He Y.
        • Maier T.
        • et al.
        Improved identification of yeast species directly from positive blood culture media by combining Sepsityper specimen processing and Microflex analysis with the matrix-assisted laser desorption ionization Biotyper system.
        J Clin Microbiol. 2011; 49: 2528-2532
        • Alshawa K.
        • Beretti J.
        • Lacroix C.
        • et al.
        Successful identification of clinical dermatophyte and Neoscytalidium species by matrix-assisted laser desorption ionization -time of flight mass spectrometry.
        J Clin Microbiol. 2012; 50: 2277-2281
        • Schrodl W.
        • Heydel T.
        • Schwartze V.U.
        • et al.
        Direct analysis and identification of pathogenic Lichtheimia species by matrix-assisted laser desorption ionization time of flight analyzer-mediated mass spectrometry.
        J Clin Microbiol. 2012; 50: 419-427
        • Sampsonas F.
        • Kontoyiannis D.P.
        • Dickey B.F.
        • et al.
        Performance of a standardized bronchoalveolar lavage protocol in a comprehensive cancer center: a prospective 2-year study.
        Cancer. 2011; 117: 3424-3433
        • Reinwald M.
        • Hummel M.
        • Kovalevskaya E.
        • et al.
        Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.
        J Antimicrob Chemother. 2012; 64: 2260-2267
        • Avni T.
        • Leibovici L.
        • Paul M.
        PCR diagnosis of invasive candidiasis: systematic review and meta-analysis.
        J Clin Microbiol. 2011; 49: 665-670
        • White P.L.
        • Bretagne S.
        • Klingspor L.
        • et al.
        Aspergillus PCR: one step closer to standardization.
        J Clin Microbiol. 2010; 48: 1231-1240
        • Forrest G.N.
        • Mankes K.
        • Jabra-Rizk M.A.
        • et al.
        Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs.
        J Clin Microbiol. 2006; 44: 3381-3383
        • Alexander B.D.
        • Ashley E.D.
        • Reller L.B.
        • et al.
        Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures.
        Diagn Microbiol Infect Dis. 2006; 54: 277-282
        • Bergeron A.
        • Porcher R.
        • Menotti J.
        • et al.
        Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients.
        J Clin Microbiol. 2012; 50: 823-830
        • Blennow O.
        • Remberger M.
        • Klingspor L.
        • et al.
        Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.
        Bone Marrow Transplant. 2010; 45: 17108
        • Hardak E.
        • Yigla M.
        • Avivi I.
        • et al.
        Impact of PCR-based diagnosis of invasive pulmonary aspergillosis on clinical outcome.
        Bone Marrow Transplant. 2009; 44: 595-599
        • Hebart H.
        • Klingspor L.
        • Klingebiel T.
        • et al.
        A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT.
        Bone Marrow Transplant. 2009; 43: 553-561
        • Smith R.M.
        • Schaefer M.K.
        • Kainer M.A.
        • et al.
        Fungal infections associated with contaminated methylprednisolone injections—preliminary report.
        N Engl J Med. 2012; ([Epub ahead of print])
        • Balajee S.A.
        • Kano R.
        • Baddley J.W.
        • et al.
        Molecular identification of Aspergillus species collected for the transplant-associated infection surveillance network.
        J Clin Microbiol. 2009; 47: 3138-3141
        • Lyons J.L.
        • Roos K.L.
        • Marr K.A.
        • et al.
        Cerebrospinal fluid (1,3) β-D-glucan detection as an aid to diagnose iatrogenic fungal meningitis.
        J Clin Microbiol. 2013; ([Epub ahead of print])
        • Chandler F.W.
        • Watts J.C.
        Pathologic diagnosis of fungal infections.
        ASCP Press, Chicago1987
        • Shinozaki M.
        • Okubo Y.
        • Sasai D.
        • et al.
        Development and evaluation of nucleic acid-based techniques for an auxiliary diagnosis of invasive fungal infections in formalin-fixed and paraffin-embedded (FFPE) tissues.
        Med Mycol J. 2012; 53: 241-245
        • Rickerts V.
        • Khot P.D.
        • Myerson D.
        • et al.
        Comparison of quantitative real time PCR with sequencing and ribosomal RNA-FISH for the identification of fungi in formalin fixed, paraffin-embedded tissue specimens.
        BMC Infect Dis. 2011; 11: 202
        • Munoz-Cadavid C.
        • Rudd S.
        • Zaki S.R.
        • et al.
        Improving molecular detection of fungal DNA in formalin-fixed paraffin-embedded tissues: comparison of five tissue DNA extraction methods using panfungal PCR.
        J Clin Microbiol. 2010; 48: 2147-2153